BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10066127)

  • 1. Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.
    Kumar R; Malik JK
    Vet Res Commun; 1998 Dec; 22(8):533-44. PubMed ID: 10066127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and residues in milk of oxytetracyclines administered parenterally to dairy goats.
    Rule R; Moreno L; Serrano JM; Roman AG; Moyano R; Garcia J
    Aust Vet J; 2001 Jul; 79(7):492-6. PubMed ID: 11549049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of experimentally induced theileriosis (Theileria annulata) on the pharmacokinetics of a long-acting formulation of oxytetracycline (OTC-LA) in calves.
    Kumar R; Malik JK
    J Vet Pharmacol Ther; 1999 Oct; 22(5):320-6. PubMed ID: 10597536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pharmacokinetics and tissue and milk residues of oxytetracycline in goats following a single intramuscular injection of a long-acting preparation and milk residues following a single subcutaneous injection.
    Payne MA; Babish JG; Bulgin M; Lane M; Wetzlich S; Craigmill AL
    J Vet Pharmacol Ther; 2002 Feb; 25(1):25-32. PubMed ID: 11874523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum oxytetracycline concentrations in African elephant (Loxodonta africana) calves after long-acting formulation injection.
    Bush M; Stoskopf MK; Raath JP; Papich MG
    J Zoo Wildl Med; 2000 Mar; 31(1):41-6. PubMed ID: 10884122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic disposition of a long-acting oxytetracycline formulation after single-dose intravenous and intramuscular administrations in the American alligator (Alligator mississippiensis).
    Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
    J Zoo Wildl Med; 2004 Sep; 35(3):341-6. PubMed ID: 15526889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oxytetracycline after intramuscular administration with lidocaine in sheep, comparison with a conventional formulation.
    Moreno L; Serrano JM; Guimerá ME; Carceles CM
    Res Vet Sci; 1998; 65(3):209-13. PubMed ID: 9915145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses.
    Dowling PM; Russell AM
    J Vet Pharmacol Ther; 2000 Apr; 23(2):107-10. PubMed ID: 10849256
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    El Korchi G; Prats C; Arboix M; Pérez B
    J Vet Pharmacol Ther; 2001 Aug; 24(4):247-50. PubMed ID: 11555179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oxytetracycline in goats: modifications induced by a long-acting formulation.
    Escudero E; Carceles CM; Serrano JM
    Vet Rec; 1994 Dec; 135(23):548-52. PubMed ID: 7886888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of endotoxin on the disposition kinetics and dosage regimens of oxytetracycline in calves.
    Kumar R; Malik JK
    J Vet Pharmacol Ther; 2003 Jun; 26(3):159-64. PubMed ID: 12755898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oxytetracycline in broiler chickens following different routes of administration.
    Ziółkowski H; Grabowski T; Jasiecka A; Zuśka-Prot M; Barski D; Jaroszewski JJ
    Vet J; 2016 Feb; 208():96-8. PubMed ID: 26681141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves.
    Schifferli D; Galeazzi RL; Nicolet J; Wanner M
    J Vet Pharmacol Ther; 1982 Dec; 5(4):247-57. PubMed ID: 7183793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Escherichia coli endotoxin induced fever on the pharmacokinetics and dosage regimen of oxytetracycline in cross-bred calves.
    Singh RP; Srivastava AK; Sharma SK; Nauriyal DC
    Acta Vet Hung; 1998; 46(1):95-100. PubMed ID: 9704514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of two long-acting oxytetracycline products administered subcutaneously and intramuscularly.
    Clarke CR; Wang Z; Cudd L; Burrows GE; Kirkpatrick JG; Brown MD
    J Vet Pharmacol Ther; 1999 Feb; 22(1):65-7. PubMed ID: 10211720
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of oxytetracycline on carprofen pharmacodynamics and pharmacokinetics in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    J Vet Pharmacol Ther; 2013 Aug; 36(4):320-8. PubMed ID: 22913421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition kinetics, bioavailability and renal clearance of cefepime in calves.
    Ismail MM
    Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between oral fluid and plasma oxytetracycline concentrations after intramuscular administration in pigs.
    Gajda A; Jablonski A; Gbylik-Sikorska M; Posyniak A
    J Vet Pharmacol Ther; 2017 Dec; 40(6):e39-e44. PubMed ID: 28456999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.